Ekene A. Enemchukwu

Urology
1000 Welch Rd Ste 100
Palo Alto, CA 94304

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications

Cost-effectiveness and patient-reported outcomes of combined versus isolated robotic rectal and pelvic organ prolapse repair: A multicentre prospective cohort study.

Cost-effectiveness and patient-reported outcomes of combined versus isolated robotic rectal and pelvic organ prolapse repair: A multicentre prospective cohort study.

Journal: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
Published: June 12, 2026

Vaginal Estrogen Utilization Among Medicare Beneficiaries With Genitourinary Syndrome of Menopause.

Vaginal Estrogen Utilization Among Medicare Beneficiaries With Genitourinary Syndrome of Menopause.

Journal: JAMA network open
Published: December 16, 2025

Health Disparities and Overactive Bladder: Bridging the Gap.

Health Disparities and Overactive Bladder: Bridging the Gap.

Journal: Current bladder dysfunction reports
Published: December 03, 2025

Chemodenervation Use for Overactive Bladder in Female Medicare Beneficiaries.

Chemodenervation Use for Overactive Bladder in Female Medicare Beneficiaries.

Journal: Urogynecology (Philadelphia, Pa.)
Published: October 15, 2025

Perception of rectal prolapse symptoms in patients with psychiatric disorders.

Perception of rectal prolapse symptoms in patients with psychiatric disorders.

Journal: World journal of gastrointestinal surgery
Published: September 22, 2025

Implant-associated malignancies in the genitourinary system: a comprehensive review of evidence and gaps.

Implant-associated malignancies in the genitourinary system: a comprehensive review of evidence and gaps.

Journal: International urology and nephrology
Published: July 11, 2025

Intravesical Onabotulinum Toxin A Injection Paradigms for Idiopathic Overactive Bladder: A Scoping Review of Clinical Outcomes, Techniques, and Implications for Practice and Future Research.

Intravesical Onabotulinum Toxin A Injection Paradigms for Idiopathic Overactive Bladder: A Scoping Review of Clinical Outcomes, Techniques, and Implications for Practice and Future Research.

Journal: Toxins
Published: March 12, 2025

Gene Therapy With URO-902 (pVAX/hSlo) for the Treatment of Female Patients With Overactive Bladder and Urge Urinary Incontinence: Safety and Efficacy From a Randomized Phase 2a Trial.

Gene Therapy With URO-902 (pVAX/hSlo) for the Treatment of Female Patients With Overactive Bladder and Urge Urinary Incontinence: Safety and Efficacy From a Randomized Phase 2a Trial.

Journal: The Journal of urology
Published: December 18, 2024

A mobile telehealth program for behavioral treatment of urinary incontinence in women Veterans: Qualitative evaluation of MyHealtheBladder.

A mobile telehealth program for behavioral treatment of urinary incontinence in women Veterans: Qualitative evaluation of MyHealtheBladder.

Journal: Journal of women & aging
Published: September 27, 2024

Trends in Overactive Bladder Therapy: Associations Between Clinical Care Pathways, Practice Guidelines, and Therapy Utilization Patterns.

Trends in Overactive Bladder Therapy: Associations Between Clinical Care Pathways, Practice Guidelines, and Therapy Utilization Patterns.

Journal: Neurourology and urodynamics
Published: July 08, 2024

Recommendations of the SUFU/AUGS/ICS Female Stress Urinary Incontinence Surgical Publication Working Group: A Common Standard Minimum Data Set for the Literature.

Recommendations of the SUFU/AUGS/ICS Female Stress Urinary Incontinence Surgical Publication Working Group: A Common Standard Minimum Data Set for the Literature.

Journal: Urogynecology (Philadelphia, Pa.)
Published: June 05, 2024

Frailty, Specialized Care, and Sociodemographic Factors: Disparities in Oral Pharmacotherapy Class Utilization Among Medicare Part D Beneficiaries With Overactive Bladder in the United States.

Frailty, Specialized Care, and Sociodemographic Factors: Disparities in Oral Pharmacotherapy Class Utilization Among Medicare Part D Beneficiaries With Overactive Bladder in the United States.

Journal: Urology
Published: April 24, 2024
Showing 1-12 of 50

Last Updated: 09/26/2026